Literature DB >> 6718837

[Thyroid function in the nephrotic syndrome].

P Y Hatron, J L Wemeau, R Guillemin, B Raviart, P Vanhille, B Devulder.   

Abstract

Serum Total Thyroxine (T4), Triiodothyronine (T3), Free Thyroxine (FT4), Free Triiodothyronine (FT3) Reverse Triiodothyronine and T3 Resin Uptake (T3RU) as well as basal and post stimulating TSH were measured in twenty clinically euthyroid patients with the nephrotic syndrome. In comparison with control values, our patients showed (1) significantly lowered mean serum TBG levels (p less than 0,05) (2) unmodified mean serum T3, FT3 and rT3 values (3) significantly lowered mean serum T4 and FT4 levels (p less than 0,001 and p = 0,027 respectively) (4) significantly higher mean basal TSH, and increased TSH response to TRH. We found a significant correlation between proteinemia and T4 or FT4 (p less than 0,001; p less than 0,01 respectively). In summary, our study: Shows that the low Total T4 observed in the Nephrotic Syndrome is not only due to a decreased protein bound T4, but also to a decreased FT4; And brings evidence for mild hypothyroidism in nephrotic patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6718837     DOI: 10.1016/s0248-8663(84)80076-4

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  3 in total

1.  Do Not Forget Nephrotic Syndrome as a Cause of Increased Requirement of Levothyroxine Replacement Therapy.

Authors:  Salvatore Benvenga; Roberto Vita; Flavia Di Bari; Poupak Fallahi; Alessandro Antonelli
Journal:  Eur Thyroid J       Date:  2015-05-28

2.  Congenital nephrotic syndrome with clinical hypothyroidism.

Authors:  M N Muranjan; A S Kher; U B Nadkarni; J R Kamat
Journal:  Indian J Pediatr       Date:  1995 Mar-Apr       Impact factor: 1.967

3.  Correlation between Oxidative Stress and Thyroid Function in Patients with Nephrotic Syndrome.

Authors:  Sangita U Sawant; Subhash Chandran; Alan F Almeida; M G R Rajan
Journal:  Int J Nephrol       Date:  2011-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.